U.S. Markets open in 6 hrs 46 mins

Aethlon Medical, Inc. (AEMD)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.5999+0.0101 (+1.71%)
At close: 03:59PM EST
0.5800 -0.02 (-3.32%)
After hours: 06:10PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.5898
Bid0.0000 x 800
Ask0.0000 x 1000
Day's Range0.5668 - 0.6150
52 Week Range0.2300 - 2.4600
Avg. Volume1,111,875
Market Cap13.765M
Beta (5Y Monthly)1.02
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Simply Wall St.

    Aethlon Medical, Inc. (NASDAQ:AEMD) Is About To Turn The Corner

    With the business potentially at an important milestone, we thought we'd take a closer look at Aethlon Medical, Inc.'s...

  • Insider Monkey

    10 Healthcare and Biotech Stocks to Buy Amid Monkeypox Threat

    In this article, we will look at 10 healthcare and biotech stocks to buy amid the monkeypox threat. If you want to explore similar healthcare and biotech stocks, you can also take a look at 5 Healthcare and Biotech Stocks to Buy Amid Monkeypox Threat. In May of 2022, the first case of the monkeypox […]

  • Benzinga

    Aethlon Medical To Start Lab Studies For Hemopurifier For Monkeypox

    Aethlon Medical Inc (NASDAQ: AEMD) said it is commissioning a new in vitro binding experiment to confirm that the Hemopurifier effectively captures the current strain of the monkeypox virus. The Hemopurifier is an extracorporeal (i.e., outside of the body) blood filtration device designed to selectively remove harmful particles from the circulatory system using lectin affinity agents. In 2008, the company conducted an in vitro study demonstrating that the Hemopurifier effectively bound and remov